Chemed Co. (NYSE:CHE) Position Trimmed by Ameritas Investment Partners Inc.

Ameritas Investment Partners Inc. trimmed its stake in Chemed Co. (NYSE:CHE) by 2.2% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,770 shares of the company’s stock after selling 106 shares during the quarter. Ameritas Investment Partners Inc.’s holdings in Chemed were worth $2,588,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also made changes to their positions in CHE. EntryPoint Capital LLC increased its stake in shares of Chemed by 14.0% in the first quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock worth $94,000 after acquiring an additional 18 shares during the last quarter. Covestor Ltd grew its stake in Chemed by 10.6% in the first quarter. Covestor Ltd now owns 219 shares of the company’s stock valued at $141,000 after purchasing an additional 21 shares in the last quarter. Ballentine Partners LLC grew its stake in Chemed by 3.4% in the first quarter. Ballentine Partners LLC now owns 660 shares of the company’s stock valued at $424,000 after purchasing an additional 22 shares in the last quarter. GAMMA Investing LLC increased its position in Chemed by 34.4% in the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock worth $47,000 after purchasing an additional 22 shares during the last quarter. Finally, Waterloo Capital L.P. raised its stake in shares of Chemed by 1.1% during the 4th quarter. Waterloo Capital L.P. now owns 2,252 shares of the company’s stock worth $1,317,000 after purchasing an additional 25 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Andrea R. Lindell sold 831 shares of the stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $571.51, for a total transaction of $474,924.81. Following the transaction, the director now owns 5,725 shares of the company’s stock, valued at approximately $3,271,894.75. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Monday, August 5th. The shares were sold at an average price of $569.63, for a total transaction of $1,139,260.00. Following the completion of the transaction, the chief executive officer now owns 105,735 shares of the company’s stock, valued at approximately $60,229,828.05. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Andrea R. Lindell sold 831 shares of the company’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $571.51, for a total transaction of $474,924.81. Following the sale, the director now owns 5,725 shares of the company’s stock, valued at $3,271,894.75. The disclosure for this sale can be found here. Insiders sold 6,744 shares of company stock valued at $3,828,231 over the last quarter. Insiders own 3.32% of the company’s stock.

Chemed Stock Performance

Shares of NYSE CHE opened at $582.06 on Friday. The business has a 50 day simple moving average of $569.34 and a 200 day simple moving average of $577.64. Chemed Co. has a 52 week low of $497.36 and a 52 week high of $654.62. The stock has a market cap of $8.81 billion, a price-to-earnings ratio of 31.33, a PEG ratio of 2.31 and a beta of 0.44.

Chemed (NYSE:CHE) last posted its earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.59 by ($0.12). The business had revenue of $595.88 million during the quarter, compared to the consensus estimate of $599.20 million. Chemed had a return on equity of 29.21% and a net margin of 12.88%. The business’s revenue was up 7.6% on a year-over-year basis. During the same period in the prior year, the firm earned $4.71 earnings per share. On average, analysts predict that Chemed Co. will post 21.77 EPS for the current year.

Chemed Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 12th were issued a dividend of $0.50 per share. This is a positive change from Chemed’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a yield of 0.34%. The ex-dividend date of this dividend was Monday, August 12th. Chemed’s dividend payout ratio (DPR) is 10.76%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.